Another healthy poison these looters deliver to taxpayers:
"Two biotechs moving operations to Boston" by Robert Weisman | September 26, 2009
A pair of Massachusetts biotechnology companies will be moving their operations to Boston with the assistance of the city’s LifeTech initiative, which provides financing, site location, and permitting assistance to life sciences companies.
Ginkgo BioWorks of Cambridge, a synthetic biology company founded by five PhDs from the Massachusetts Institute of Technology, plans to move to Marine Industrial Park on the South Boston Waterfront. The company received a $150,000 LifeTech innovation fund loan through Boston Local Development Corp.
Eutropics Pharmaceuticals of Woburn, a Harvard Medical School spinoff that develops small molecule treatments for blood cancers, will relocate to 609 Albany Ave. on the Boston University Medical School campus at BioSquare. Eutropics has been approved for an unspecified loan by the LifeTech advisory committee.
Mayor Thomas M. Menino will formally announce the moves at a press conference Monday.He going to issue an apology to the towns losing them?
A check?
Anything?
--more--"
